Descubra cómo hemos abordado los puntos débiles de la industria en ensayos clínicos anteriores. A continuación, encontrará nuestros estudios de casos más recientes.
A multi-national European pharmaceutical and consumer health company required clinical data to validate the safety and performance of five of its nasal spray and allergy products post CE-mark, in accordance with MDR 2017/745 Annex XIV Part B.
A multinational food and beverage company sought to analyze the prevalence of functional gastrointestinal disorders (FGIDs) and the efficacy of FGID treatments for Thai infants and toddlers.
Studying a medical device for the treatment of overactive bladder. ObvioHealth is conducting an innovative study seeking FDA approval of a wearable neuromodulation device for the treatment of overactive bladder (OAB).
Lycored, a leader in carotenoid-based wellness products, sought to understand the consumer-perceived efficacy of a tomato-based supplement through twelve subjective skin indicators.